CSHL Story archive for Tag: Christopher Vakoc

Christina Renna Foundation gives $35k for pediatric cancer research

February 7, 2019

The Christina Renna Foundation donated $35,000 to CSHL for continued work on Sarcoma Research Project and research into RMS.

The year of CRISPR

December 26, 2018

A look at the various labs across CSHL that utilize CRISPR in their research, and the groundbreaking discoveries they help uncover.

Inconspicuous protein key to deadly blood cancer

November 29, 2018

Associate Professor Chris Vakoc and his team find that an aggressive type of leukemia is heavily-dependent on a common protein.

Pancreatic cancer’s addiction could be its end

November 13, 2018

Researchers may have found a link between improper protein production and the spread of pancreatic cancer.

Friends of T.J. donate $50k for sarcoma research

October 9, 2018

Associate Professor Chris Vakoc and his team receive a donation to further their rhabdomyosarcoma research.

Researchers discover new type of lung cancer

June 25, 2018

Researchers have discovered a new form of lung cancer.

CRISPR-based system identifies important new drug targets in a deadly leukemia

March 8, 2018

CRISPR was used to find 2 new druggable targets in a deadly leukemia

Molecular decoy helps researchers halt and reverse acute leukemia in mice

January 8, 2018

By throwing a molecular wrench into the gears of a machine that sets genes into motion, researchers were able to get leukemias to 'melt away.'

Friends of T.J. present $50,000 gift for ongoing rhabdomyosarcoma research

November 7, 2017

The Friends of T.J. Foundation presented CSHL Associate Professor Chris Vakoc with a check for $50,000 for his ongoing rhabdomysarcoma research

Halfway around the world, a reunion of friends opens door to a cancer discovery

August 31, 2017

After interviewing for a position in a pancreatic cancer lab at Cold Spring Harbor Laboratory, 7,000 miles from his hometown in South Korea, Chang-il.

Chris Vakoc

July 29, 2017

Cold Spring Harbor Laboratory sarcoma research update

January 4, 2017

CSHL has applied its excellence in basic research and innovative technology development to understanding the rare but intractable sarcoma cancers.

Why calling childhood cancers “rare” is missing the point

September 19, 2016

Associate Professor Christopher Vakoc on why calling pediatric cancers "rare" actually hurts their chances of being studied.

Academic-industry collaboration generates elegant way of pinpointing how a new drug exerts beneficial effects

July 5, 2016

Researchers identify a new drug target in leukemia and creation of a candidate drug that hits the target.

Pershing Square Sohn Cancer Research Alliance awards prize to CSHL’s Christopher Vakoc

May 27, 2016

Associate Professor Christopher Vakoc of Cold Spring Harbor Laboratory is among seven winners of the third annual Pershing Square Sohn Prize